Industry Roundup: Church & Dwight Earnings, Nicoderm CQ Label Warning
This article was originally published in The Tan Sheet
Executive Summary
AstaZine carries 239 structure/function claims; FDA warns on misbranded supplements, cosmetics; Georgia joins NPLEx; and more news in brief.
You may also be interested in...
Drug-Spiked Coffee Recalled With Link To Death Suspected
Malaysian firm marketing spiked product states on its e-commerce site, "Warning … please make sure you are healthy enough to accept these wonderful new changes."
Weight Loss Claims Land Firms On FTC Radar In First ‘Negative Option’ Case
FTC says Health Formulas LLC of Las Vegas, and its associated firms in Nevada and California, make unsubstantiated claims for green coffee bean extract and other supplement products. A judge issued a temporary injunction against the firms from using “free” trial offers and deceptive health claims.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”